Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026)

Pacific Biosciences Of California has reported Other Non-Current Assets for 17 years, with the latest figure at $13.5 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 49.73% year-over-year to $13.5 million in Q2 2026; TTM through Jun 2026 was $13.5 million, a 49.73% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, down 5.72% from the prior year.
• Other Non-Current Assets was $13.5 million for Q2 2026 at Pacific Biosciences Of California, down from $14.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $14.2 million in Q1 2026, with the low at $2.9 million in Q2 2022.
• Average Other Non-Current Assets over 5 years is $9.8 million, with a median of $9.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 349.79% in 2023, then declined 29.9% in 2024.
• Over 5 years, Other Non-Current Assets stood at $10.5 million in 2022, then advanced by 26.08% to $13.3 million in 2023, then slipped by 29.9% to $9.3 million in 2024, then fell by 5.72% to $8.8 million in 2025, then soared by 53.79% to $13.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $13.5 million (Q2 2026), $14.2 million (Q1 2026), and $8.8 million (Q4 2025), per Business Quant data.